Healthcare -
Biotechnology - NASDAQ - US
$ 14.25
-4.55 %
$ 2.42 B
Market Cap
-5.52
P/E
IMVT - REVENUE
Revenue IMVT - Immunovant, Inc.
0
LAST VALUE
0.00%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR